| ISIN | CH0539033388 |
|---|---|
| Valor Number | 53903338 |
| Bloomberg Global ID | |
| Fund Name | PI (CH) - European ex Swiss Equities Tracker -Z0 EUR |
| Fund Provider |
Pictet Asset Management S.A.
Genève, Switzerland Phone: +41 58 323 10 24 www.assetmanagement.pictet |
| Fund Provider | Pictet Asset Management S.A. |
| Representative in Switzerland | |
| Distributor(s) |
Credit Suisse AG Zürich Phone: +41 44 333 11 11 UBS AG Zürich Phone: +41 44 234 11 11 Vontobel Fonds Services AG Zürich Phone: +41 58 283 74 77 |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Distribution |
| Home Country | Switzerland |
| Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
| Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
| Investment Strategy *** | This fund invests in equities of public companies included in the MSCI Europe ex−CH index. |
| Peculiarities |
| Current Price * | 1,828.37 EUR | 20.11.2025 |
|---|---|---|
| Previous Price * | 1,820.80 EUR | 19.11.2025 |
| 52 Week High * | 1,898.12 EUR | 12.11.2025 |
| 52 Week Low * | 1,488.97 EUR | 09.04.2025 |
| NAV * | 1,828.37 EUR | 20.11.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 419,973,214 | |
| Unit/Share Assets *** | 224,811,471 | |
| Trading Information SIX | ||
| YTD Performance | +12.93% |
31.12.2024 - 20.11.2025
31.12.2024 20.11.2025 |
|---|---|---|
| YTD Performance (in CHF) | +11.62% |
31.12.2024 - 20.11.2025
31.12.2024 20.11.2025 |
| 1 month | -1.40% |
20.10.2025 - 20.11.2025
20.10.2025 20.11.2025 |
| 3 months | +1.08% |
20.08.2025 - 20.11.2025
20.08.2025 20.11.2025 |
| 6 months | +2.64% |
20.05.2025 - 20.11.2025
20.05.2025 20.11.2025 |
| 1 year | +14.95% |
20.11.2024 - 20.11.2025
20.11.2024 20.11.2025 |
| 2 years | +29.06% |
20.11.2023 - 20.11.2025
20.11.2023 20.11.2025 |
| 3 years | +31.43% |
25.08.2023 - 20.11.2025
25.08.2023 20.11.2025 |
| 5 years | - | - |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SAP SE | 2.82% | |
|---|---|---|
| ASML Holding NV | 2.60% | |
| AstraZeneca PLC | 2.19% | |
| HSBC Holdings PLC | 2.03% | |
| Shell PLC | 2.02% | |
| Siemens AG | 1.85% | |
| Novo Nordisk AS Class B | 1.46% | |
| Allianz SE | 1.44% | |
| Lvmh Moet Hennessy Louis Vuitton SE | 1.40% | |
| Unilever PLC | 1.38% | |
| Last data update | 31.07.2025 | |
| TER *** | 0.02% |
|---|---|
| TER date *** | 31.12.2024 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.26% |
| Ongoing Charges *** | 0.02% |
|
SRRI ***
|
|
| SRRI date *** | 31.10.2025 |